Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025

Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025#Akero #Therapeutics #HistoIndex #Present #Analyses #Phase #HARMONY #Trial #Oral #Poster #Presentations #EASL #Congress